Going concern
Filing comparison
Galera Therapeutics, Inc.'s going-concern disclosure changed
Substantial doubt about ability to continue as a going concern → Risk-factor language only
The principal risks and uncertainties affecting our business include the following: • We are a biopharmaceutical company with a limited operating history and have not generated any revenue from product sales. We have incurred significant operating losses since our inception and anticipate that we will incur continued losses for the foreseeable future. • Our ability to continue as a going concern is dependent on obtaining additional funding, and failure to secure such funding could significantly impair our operations. • We previously halted clinical development of all but one of our product…
Evidence
- Blank check
- No
- Comparable
- Yes
- Current state
- risk_factor_only
- Current state label
- Risk-factor language only
- Direction
- eased
- Located in
- risk factors / forward-looking statements only
- Prior filed
- 2025-03-31
- Prior form
- 10-K
- Prior state
- substantial_doubt
- Prior state label
- Substantial doubt about ability to continue as a going concern
- Source
- ASC 205-40 going-concern note comparison
- Why
- Disclosure about the company's ability to continue as a going concern changed compared with its previous report.